Ceccon, G.; Werner, J.-M.; Dunkl, V.; Tscherpel, C.; Stoffels, G.; Brunn, A.; Deckert, M.; Fink, G.R.; Galldiks, N.
Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation. Int. J. Mol. Sci. 2018, 19, 1090.
https://doi.org/10.3390/ijms19041090
AMA Style
Ceccon G, Werner J-M, Dunkl V, Tscherpel C, Stoffels G, Brunn A, Deckert M, Fink GR, Galldiks N.
Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation. International Journal of Molecular Sciences. 2018; 19(4):1090.
https://doi.org/10.3390/ijms19041090
Chicago/Turabian Style
Ceccon, Garry, Jan-Michael Werner, Veronika Dunkl, Caroline Tscherpel, Gabriele Stoffels, Anna Brunn, Martina Deckert, Gereon R. Fink, and Norbert Galldiks.
2018. "Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation" International Journal of Molecular Sciences 19, no. 4: 1090.
https://doi.org/10.3390/ijms19041090
APA Style
Ceccon, G., Werner, J.-M., Dunkl, V., Tscherpel, C., Stoffels, G., Brunn, A., Deckert, M., Fink, G. R., & Galldiks, N.
(2018). Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation. International Journal of Molecular Sciences, 19(4), 1090.
https://doi.org/10.3390/ijms19041090